Platin Pharma is established under Platin Group at 2004 for supplying active pharmaceutical ingredients (APIs) and excipients for pharmaceutical industry as 100% Turkish capital. In addition to supply service to industry, we; as Platin; has launched innovative finished products in Turkish market as well.
Our first product was finished product including Ondansetron with Orodispersible Tablet (ODT) form as first generic in Turkey at 2009. This was followed by finished product including Zoledronic Acide with Sterile Flacon form again as first generic in Turkey at 2016.
Up to day we have reached 14 marketing authorizations (MAs) including 8 different APIs. Platin Pharma has initiated promotional activities with setup of Physiotheraphy & Orthopedia sales and marketing (S&M) team at 2019. For the near future we are getting prepared for new business units (BUs) for Gynecology, Urology and Dermatology areas as well.
Our target is to presence strongly in pharmaceutical market with our own brands. In accordance to this target, we are establishing our own R&D laboratory with 300m2 closed area in 2020. We will enhance our contribution on social health and national economy with the products that are developed by our own R&D team.